Luminus Management LLC Oncorus, Inc. Transaction History

Luminus Management LLC

  • $170 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$13.3 - $17.3 $5.83 Million - $7.58 Million
-438,300 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$11.89 - $35.55 $5.21 Million - $15.6 Million
438,300 New
438,300 $6.1 Million

About Oncorus, Inc.

ONCR Quotes by TradingView
  • Ticker ONCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,973,100
  • Description
  • Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...
More about ONCR
Track This Portfolio

Track Luminus Management LLC Portfolio

Follow Luminus Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Luminus Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Luminus Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email